- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06440590
Supra-Pectineal QLS Plating Vs Infra-pectineal Plating in Management of Quadrilateral Plate Fractures
July 29, 2024 updated by: Islam Moussa, Ain Shams University
Supra-Pectineal Quadrilateral Buttress Plating Versus Infra-pectineal Plating in Management of Quadrilateral Plate Fractures: A Randomized Controlled Trial
The investigators conducted such a prospective randomized controlled study aiming to reach a satisfactory outcome and to compare supra-pectineal QL buttress plating versus infra-pectineal for management of anterior column with or without posterior hemi-transverse component and quadrilateral plate involvement.
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Detailed Description
Our hypothesis was that supra-pectineal quadrilateral buttress plating provides much more rigid fixation and a strong buttress for medial wall migration, also it could correlate with a better functional and radiological outcome.
However, there is a lack of knowledge in the prospective assessment of functional and radiological outcomes and follow up of postoperative complications of supra-pectineal quadrilateral buttress plating versus infra-pectineal plating in fixation of QLS and to our knowledge, it will be the first study to include such measures of outcome together in a prospective randomized fashion.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Abassia
-
Cairo, Abassia, Egypt, 1234
- Ain Shams University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Anterior column fracture acetabulum with QLS involvement
- Anterior column posterior hemi-transverse fracture acetabulum with QLS involvement
- Age between 16-60 years' old
Exclusion Criteria:
- Open fractures
- Associated pelvic ring injuries that require intervention
- Associated internal organ injuries that require intervention
- Age less than 14 years and older than 60 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: supra-pectineal quadrilateral buttress plating
Patients treated by supra-pectineal quadrilateral buttress plating through anterior intrapelvic approach
|
15 cases will undergo anatomical supra-pectineal quadrilateral plate
|
|
Active Comparator: Infrapectineal plating
Patients treated by infra-pectineal conventional plating applied on the medial wall through anterior intrapelvic approach
|
15 cases will undergo conventional manually contoured infra-pectineal plate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Excellent, very good, Good, Average or Poor functional outcomes using Modified Merle d'Aubigné scoring system
Time Frame: one-year post-operative
|
Clinical assessment was done via Modified Merle d'Aubigné scoring system that was calculated at each follow-up visit (out of 18) and presented the mean value; the score evaluates three factors: pain, mobility & ability to walk. the score maximum being 18 (excellent) and minimum 6 (poor)
|
one-year post-operative
|
|
Rate of Anatomical, Congruent or Incongruent Radiological Outcomes using Matta & Tornetta radiological principles
Time Frame: 1 year postoperative
|
Radiological assesment was done according to the grading of Matta and Tornetta, The investigators classified the results into: Anatomical, congruent & incongruent; based on the restoration of the five anatomical lines (iliopectineal line, ilioischial line, acetabular dome, posterior wall & anterior wall) & best judged on the anteroposterior view.
|
1 year postoperative
|
|
Amount of residual displacement
Time Frame: immediate post-operative and throughout study completion
|
Residual displacement was measured in millimeters and compared between the two study groups
|
immediate post-operative and throughout study completion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
post-operative complications' rate
Time Frame: 1-year post-operative
|
The investigators focused the evaluation of Postoperative complications on the local complications related to fixation principles and technique: LLD, AVN of the hip joint, wound infection, residual malunion or non-union of the quadrilateral plate, and loss of reduction
|
1-year post-operative
|
|
Mean intraoperative blood loss
Time Frame: up to 4 days post-operative
|
The mean blood loss was calculated and compared between the two study groups, it was measured intraoperative and postoperative from suction drains
|
up to 4 days post-operative
|
|
Mean operative time
Time Frame: it was calculated intra-operative
|
The mean operation time was calculated in minutes and compared between the two study groups
|
it was calculated intra-operative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Islam S Moussa, MD, no funding recieved
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2023
Primary Completion (Actual)
July 10, 2024
Study Completion (Estimated)
August 20, 2024
Study Registration Dates
First Submitted
May 26, 2024
First Submitted That Met QC Criteria
June 3, 2024
First Posted (Actual)
June 4, 2024
Study Record Updates
Last Update Posted (Actual)
July 30, 2024
Last Update Submitted That Met QC Criteria
July 29, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FMASU R66/2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
i plan to share it with other researchers
IPD Sharing Time Frame
one year
IPD Sharing Access Criteria
full access
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.